Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pain 2Uterine Diseases 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Mouth Neoplasms 1Lung Neoplasms 1Leiomyoma 1Dysmenorrhea 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1

Interventions

Bevacizumab 7Talc 4Pleurodesis 4Thoracoscopy 3Povidone-Iodine 3Paclitaxel 3Drug Therapy 3Doxycycline 3Docetaxel 3Cisplatin 3Chest Tubes 3Carboplatin 3aldesleukin 2Thoracentesis 2Taxes 2Surveys and Questionnaires 2Sodium Chloride 2Silver Nitrate 2Pharmaceutical Preparations 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-2 2High-Energy Shock Waves 2Gemcitabine 2Fentanyl 2tocilizumab 1talimogene laherparepvec 1romidepsin 1lipoplatin 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pleural Effusion, Malignant × Naproxen × Clear all
NCT01612975 2018-02-15

The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection

McMaster University

Phase 2 Terminated
7 enrolled
Thoracic

Lung Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡